N-[4-(3-methoxy-3-methylbutoxy)-4-methylpentyl]-N-methyl-2-tetradecylhexadecan-1-amine
C43H89NO2 — CID 123325195
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-(3-methoxy-3-methylbutoxy)-4-methylpentyl]-N-methyl-2-tetradecylhexadecan-1-amine
N-[4-(3-methoxy-3-methylbutoxy)-4-methylpentyl]-N-methyl-2-tetradecylhexadecan-1-amine (PubChem CID 123325195) has the molecular formula C43H89NO2 and a molecular weight of 652.19 g/mol. Its IUPAC name is N-[4-(3-methoxy-3-methylbutoxy)-4-methylpentyl]-N-methyl-2-tetradecylhexadecan-1-amine.
Molecular Properties
| Compound Name | N-[4-(3-methoxy-3-methylbutoxy)-4-methylpentyl]-N-methyl-2-tetradecylhexadecan-1-amine |
|---|---|
| PubChem CID | 123325195 |
| Molecular Formula | C43H89NO2 |
| Molecular Weight | 652.19 g/mol |
| Exact Mass | 651.69 |
| IUPAC Name | N-[4-(3-methoxy-3-methylbutoxy)-4-methylpentyl]-N-methyl-2-tetradecylhexadecan-1-amine |
| SMILES | CCCCCCCCCCCCCCC(CCCCCCCCCCCCCC)CN(C)CCCC(C)(C)OCCC(C)(C)OC |
| InChI | InChI=1S/C43H89NO2/c1-9-11-13-15-17-19-21-23-25-27-29-31-34-41(35-32-30-28-26-24-22-20-18-16-14-12-10-2)40-44(7)38-33-36-43(5,6)46-39-37-42(3,4)45-8/h41H,9-40H2,1-8H3 |
| InChIKey | USAKZTVYWUSCSV-UHFFFAOYSA-N |
| XLogP | 14.11 |
| TPSA | 21.70 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 37 |
| Heavy Atoms | 46 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 652.19 |
| LogP ≤ 5 | 14.11 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123325195 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.